Hypokalemia Associated with Hydrochlorothiazide (HCTZ) Use

Introduction to HCTZ-Induced Hypokalemia

The Annual Review of Nutrition confirms that HCTZ treatment results in lower serum potassium levels compared to control groups (p=0.0001) 1

Regular monitoring of serum electrolytes, particularly within 4 weeks of initiation and after dose escalation, is recommended to prevent or manage HCTZ-induced hypokalemia 2
Using the lowest effective dose of HCTZ (typically 12.5-25mg) minimizes hypokalemia risk 2
Potassium supplementation may be necessary, though it may not fully correct HCTZ-induced hypokalemia 2
Chlorthalidone's longer duration of action (40-60 hours vs. 6-12 hours for HCTZ) contributes to its higher risk of hypokalemia 2